VIROMED MEDICAL NA O.N. Market Cap ($116.27 Million)
Market Cap & Net Worth: VIROMED MEDICAL NA O.N. (VME)
VIROMED MEDICAL NA O.N. market cap. VIROMED MEDICAL NA O.N. (XETRA:VME) has a market capitalization of $116.27 Million (€99.45 Million) as of November 1, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #18431 globally and #1709 in its home market, demonstrating a -2.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VIROMED MEDICAL NA O.N.'s stock price €4.68 by its total outstanding shares 21250000 (21.25 Million).
VIROMED MEDICAL NA O.N. Market Cap History (2026–2026)
VIROMED MEDICAL NA O.N. market cap history from 2026 to 2026. Data shows growth from $116.27 Million to $116.27 Million (0.00% CAGR). Check VME live share price for real-time trading data and today's change.
VIROMED MEDICAL NA O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VIROMED MEDICAL NA O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VIROMED MEDICAL NA O.N. equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VME by Market Capitalization
Companies near VIROMED MEDICAL NA O.N. in the global market cap rankings as of November 1, 2026. Also see VIROMED MEDICAL NA O.N. balance sheet assets for a full breakdown of the balance sheet.
Key companies related to VIROMED MEDICAL NA O.N. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of VIROMED MEDICAL NA O.N. (2026–2026)
Market capitalization of VIROMED MEDICAL NA O.N. from 2026 to today. Between 2026 and today, VIROMED MEDICAL NA O.N.'s market cap moved from $116.27 Million to $ 116.27 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €116.27 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of VIROMED MEDICAL NA O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $116.27 Million USD |
| MoneyControl | $116.27 Million USD |
| MarketWatch | $116.27 Million USD |
| marketcap.company | $116.27 Million USD |
| Reuters | $116.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.